Page 2 - Conditional Marketing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

BRUSSELS, Dec. 20 (Xinhua) -- The European Commission on Monday granted conditional marketing authorization for Nuvaxovid, the fifth COVID-19 vaccine authorized

Press release content from Business Wire. The AP news staff was not involved in its creation.

FinancialContent fully hosted finance channel

The biotech announced three major regulatory updates for its COVID-19 vaccine this morning.

The biotech announced three major regulatory updates for its COVID-19 vaccine this morning.

Health Canada filing marks first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in Canada Submission of all modules...

Sanofi to help manufacture Janssen COVID-19 vaccine Sanofi’s vaccine manufacturing plant in Marcy l’Etoile, France, will formulate and fill vials of Janssen’s COVID-19 vaccine: producing around 12 million doses a month to help address global supply demands. Situated outside of Lyon, Sanofis facility covers vaccine research, development and production. It produces vaccines against diseases such as diphtheria, typhoid, tetanus, polio and whooping cough.  Sanofis...

CureVac has initiated a rolling review with the European Medicines Agency (EMA), working towards authorization for its mRNA COVID-19 vaccine in the European Union. The candidate is currently in Phase 3 trials in Europe and Latin America, and the rolling review with the EMA is its first submission for authorization globally. Phase 1 interim data, announced in November, showed that CVnCoV was generally well tolerated across all tested doses and induced strong antibody...

Celltrion’s COVID-19 treatment candidate receives Korean MFDS Conditional Marketing Authorisation     Regdanvimab (CT-P59) receives conditional marketing authorisation from the Korean Ministry of Food and Drug Safety (MFDS); first anti-COVID-19 monoclonal antibody treatment to be approved in Korea  CT-P59 is authorised for the treatment of adult patients aged 60 and over, or with at least one underlying medical condition, with mild symptoms of COVID-19, and adult patients...